Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1988-12-12
|
pubmed:abstractText |
The potential proficiency of radioimmunoguided surgery in the intraoperative detection of tumors was assessed using labeled monoclonal antibody B72.3 in 66 patients with tissue-proved tumor. Monoclonal antibody B72.3 was injected 5 to 42 days preoperatively, and the hand-held gamma-detecting probe was used intraoperatively to detect the presence of tumor. Intraoperative probe counts of less than 20 every 2 seconds, or tumor-to-adjacent normal tissue ratios less than 2:1 were considered negative (system failure). Positive probe counts were detected in 5 of 6 patients with primary colon cancer (83 percent), in 31 of 39 patients with recurrent colon cancer (79 percent), in 4 of 5 patients with gastric cancer (80 percent), in 3 of 8 patients with breast cancer (37.5 percent), and in 4 of 8 patients with ovarian cancer (50 percent) undergoing second-look procedures. Additional patients in each group were scored as borderline positive. Overall, radioimmunoguided surgery using B72.3 identified tumors in 47 patients (71.2 percent), bordered on positive in 6 patients (9.1 percent), and failed to identify tumor in 13 patients (19.7 percent). Improved selection of patients for antigen-positive tumors, the use of higher affinity second-generation antibodies, alternate routes of antibody administration, alternate radionuclides, and more sophisticatedly bioengineered antibodies and antibody combinations should all lead to improvements in radioimmunoguided surgery.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0002-9610
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
386-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3189709-Antibodies, Monoclonal,
pubmed-meshheading:3189709-Breast Neoplasms,
pubmed-meshheading:3189709-Colonic Neoplasms,
pubmed-meshheading:3189709-False Negative Reactions,
pubmed-meshheading:3189709-Female,
pubmed-meshheading:3189709-Humans,
pubmed-meshheading:3189709-Intraoperative Period,
pubmed-meshheading:3189709-Iodine Radioisotopes,
pubmed-meshheading:3189709-Neoplasm Recurrence, Local,
pubmed-meshheading:3189709-Ovarian Neoplasms,
pubmed-meshheading:3189709-Scintillation Counting,
pubmed-meshheading:3189709-Stomach Neoplasms
|
pubmed:year |
1988
|
pubmed:articleTitle |
Radioimmunoguided surgery using monoclonal antibody.
|
pubmed:affiliation |
Department of Surgery, Ohio State University College of Medicine, Columbus.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|